Cooley advised Procyrion on the transaction, and Wilson Sonsini Goodrich & Rosati advised lead investor Fannin Partners. Procyrion, Inc. announced it completed a $57.7 million Series E...
Procyrion’s $57.7 Million Series E Financing Round
Kite’s Acquisition of Tmunity
Cooley advised Tmunity on the deal. Tmunity, a clinical-stage biotechnology company, announced its agreement to sell to Kite, a global biopharmaceutical company. The acquisition will provide...
Boston Scientific’s Acquisition of Apollo Endosurgery
Cooley LLP advised Apollo Endosurgery on the deal, while Shearman & Sterling advised Boston Scientific Corporation. Apollo Endosurgery, a medical device company, signed the agreement to be...
Vaxcyte’s $690 Million Public Offering
Cooley advised Vaxcyte, while Latham & Watkins represented the underwriters on the offering. Vaxcyte, a clinical-stage vaccine innovation company, announced its underwritten public offering of common stock and...